Drug Topics

AUGUST 23, 2024

Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.

187

187

Pharmacy Times

AUGUST 23, 2024

The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.

FDA 149

FDA 149

STAT

AUGUST 23, 2024

I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent most disease and a lot of what we do in medicine doesn’t add value and sometimes even causes harm. So instead, I practice a seemingly radical but necessary idea for getting the best from medicine while avoiding excesses.

145

145

Fierce Pharma

AUGUST 23, 2024

Bayer’s latest round of layoffs has reportedly hit Basel, Switzerland, home of the international headquarters of the company's consumer health division. | The layoffs are the latest in Bayer's massive restructuring plan that has so far impacted more than 3,000 staffers since the start of the year.

140

140

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

AUGUST 23, 2024

The use of artificial intelligence in hospitals is ramping up so fast — and with such little transparency — that it is impossible to track how any given product is impacting the cost or quality of care. Whether AI is monitored at all is entirely up to individual health systems.   “Everybody is doing this differently, and many health systems are not doing it,” said Mike Pencina, chief data scientist at Duke Health.

Hospitals 140

Hospitals 140

Drug Topics

AUGUST 23, 2024

Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the importance of cooling medications in the rising heat of the summer months.

112

112

Fierce Healthcare

AUGUST 23, 2024

The healthcare industry confronts a complex, double-barreled challenge as it tries to combat the recent deluge of dangerous and damaging cyberattacks. | Cyber resilience is the ability to recognize threats, respond to them, recover quickly and at scale. The clear goal: fending off attacks more efficiently, limiting damage and restoring normal operations with minimal impact to patients.

137

137

STAT

AUGUST 23, 2024

Several years ago, while on a road trip, I ordered the now-discontinued spaghetti and meatballs during a pitstop at Denny’s. When the plate came out, I thought there was no way I could finish the massive platter, but then I did because it was right in front of me — even though I knew exactly what was going on. As an assistant professor of health policy, I examine the food environment and how we can encourage healthier choices.

Packaging 126

Packaging 126

Fierce Pharma

AUGUST 23, 2024

The FDA has authorized the use of | The FDA has authorized the use of new vaccines from Pfizer/BioNTech and Moderna which have been designed to defend against the Omicron KP.2 variant of SARS-CoV-2. The nod comes as word of a new omicron variant, KP.3.1.1, is beginning to eclipse KP.2 as the dominant strain of the virus in the United States.

Vaccines 119

Vaccines FDA 119

STAT

AUGUST 23, 2024

A diagnostics company has agreed to stop selling two questionable blood tests as part of a settlement with a consumer watchdog that accused the firm of using “false and misleading advertising” to promote the products.  Not only was EpicGenetics claiming that one of its blood tests could definitively diagnose fibromyalgia, the Center for Science in the Public Interest’s October 2023 lawsuit said; the company had also invented a disease wholesale to justify the use of ano

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

AUGUST 23, 2024

While some analysts figure Jazz Pharmaceuticals’ Epidiolex—sold as Epidyolex abroad—could surpass the blockbuster sales threshold by the end of the decade, the cannabidiol-based seizure drug has st | On Friday, Jazz revealed that its Epidiolex oral solution failed to mass muster in a late-stage study when used as an adjunct treatment for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS) or tuberous sclerosis complex (TSC) in young Japanese patients.

113

113

STAT

AUGUST 23, 2024

A U.S. government agency said that a planned move by Johnson & Johnson to alter payment methods for some hospitals participating in a controversial drug discount program was “inconsistent” with federal law and requires approval before the company can proceed. The statement by the U.S. Health Resources and Services Administration came in response to a J&J plan to issue rebates for two widely prescribed medicines instead of offering discounted prices.

Hospitals 118

Hospitals 118

pharmaphorum

AUGUST 23, 2024

Discover how patient organizations play a key role in enabling drug development with the support of EFPIA. Learn more about their involvement and impact in the pharmaceutical industry.

109

109

Pharmacy Times

AUGUST 23, 2024

Bendamustine resulted in a greater risk of treatment complications in patients with lymphoma.

137

137

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

AUGUST 23, 2024

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent months.Both new mRNA-based vaccines have been approved for use in people aged 12 and over – and been granted emergency use authorisation for younger people aged 6 months to 11 years – and will be available within the next few days, said the drugmakers.

FDA 103

FDA Vaccines 103

Fierce Healthcare

AUGUST 23, 2024

OMNY, a national data ecosystem that covers 75 million lives, is launching a GLP-1 (glucagon-like peptides) database. | OMNY is a national platform that helps health systems and researchers draw insights from patient records. Its newest offering will help create certainty about the impacts of GLP-1s.

110

110

Pharmacy Times

AUGUST 23, 2024

This designation follows the drug's rare pediatric disease designation in July 2024.

FDA 132

FDA 132

STAT

AUGUST 23, 2024

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. Happy Friday! Isa here. As a Floridian, my school year always started mid-August, so my internal clock is primed to think of this time as summer’s end. It’s an agony I plan to treat with mango ice cream until the pumpkin spice people break down my front door.

Vaccines 105

Vaccines FDA 105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

AUGUST 23, 2024

Novartis and VC Versant set up a new biotech, Borealis Biosciences, using a similar model to an earlier alliance to create Chinook Therapeutics

108

108

Pharmacy Times

AUGUST 23, 2024

Investigators compare the impact of semaglutide for preserved ejection fraction and reduced ejection fraction, which both have different causes and responses to treatment.

93

93

pharmaphorum

AUGUST 23, 2024

AstraZeneca says rumours that it will relocate a planned vaccines facility from the UK to the US "do not seem to be based on facts"

Vaccines 108

Vaccines 108

STAT

AUGUST 23, 2024

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still on the drawing board, but we do plan to catch up on our reading and napping, promenade with the official mascots, and hold another listening party with Mrs. Pharmalot, and the rotation will likely include this , this , this , this and this.

Vaccines 99

Vaccines Packaging 99

pharmaphorum

AUGUST 23, 2024

Discover how apps and telemedicine are driving growth in the healthcare industry with connected health solutions. Learn about the impact of technology on patient care and access to services.

Patient Care 96

Patient Care 96

Pharmacy Times

AUGUST 23, 2024

The researchers found that unusual and dramatic changes in weather as well as heavy rainfall helped aid in the pathogen’s evolutionary change.

132

132

pharmaphorum

AUGUST 23, 2024

Zenas BioPharma has filed an initial public offering in the US seeking $100m+ for obexelimab, a therapy for rare disease IgG4-RD in phase 3

104

104

Fierce Pharma

AUGUST 23, 2024

For the last 40 years, when federal legislation was ambiguous or left an administrative ga | This week on "The Top Line," we look at the potential effects of the Chevron overturn on the biopharma industry.

88

88

pharmaphorum

AUGUST 23, 2024

ICER says Geron's new drug Rytelo for myelodysplastic syndromes (MDS) is priced three to four times higher than it should be

102

102

Pharmaceutical Technology

AUGUST 23, 2024

Novartis has partnered with Versant Ventures to establish Borealis Biosciences, a Canada based independent, discovery-stage biotech company.

98

98

Fierce Healthcare

AUGUST 23, 2024

Evolent Health, a company that offers software solutions to help providers and insurers transition to value-based care, is reportedly in talks for an acquisition after receiving take | Evolent Health is in talks with three private equity firms and a health insurer who have expressed interest in purchasing the company, Reuters reported on Thursday. In response to the news, Evolent's stock price jumped 14%.

Insurance 80

Insurance 80

Pharmacy Times

AUGUST 23, 2024

Pharmacists can help caregivers by recommending a healthy balanced diet containing high vitamin D intake and supplementation when needed.

123

123

Outsourcing Pharma

AUGUST 23, 2024

DirectSens, an Austrian biosensor developer, has launched its latest innovation, the XpressGT RUO kit, designed for the detection of conditions related to insulin resistance, including gestational diabetes (GDM), endometriosis, and liver disease.

85

85

Pharmaceutical Technology

AUGUST 23, 2024

The two companies have expanded their agreement first inked in 2023, with a second ‘high-value target’ now in the crosshairs.

95

95

Outsourcing Pharma

AUGUST 23, 2024

Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European Commission (EC) has approved Balversa (erdafitinib) as a once-daily oral monotherapy for adult patients with unresectable or metastatic urothelial carcinoma (mUC) harboring susceptible FGFR3 genetic alterations.

85

85